Guangdong Key Laboratory of Functional Substances in Medicinal Edible Resources and Healthcare Products, Hanshan Normal University, Chaozhou 521041, China; Shantou University Medical College, Shantou 515000, China; Guangdong Taiantang Pharmaceutical Co., Ltd. Shantou 515000, China.
Industrial College of Biomedicine and Health Industry, Youjiang Medical University for Nationalities, Baise 533000, China.
Poult Sci. 2024 Oct;103(10):104141. doi: 10.1016/j.psj.2024.104141. Epub 2024 Aug 3.
Rapid and accurate detection of goose parvovirus (GPV) is crucial for controlling outbreaks and mitigating their economic impact on the poultry industry. This study introduces recombinase polymerase amplification combined with the Pyrococcus furiosus argonaute (RPA-PfAgo) system, a novel diagnostic platform designed to address the limitations of traditional GPV detection methods. Capitalizing on the rapid DNA amplification of RPA and stringent nucleic acid cleavage by the PfAgo protein, the RPA-PfAgo system offers high specificity and sensitivity in detecting GPV. Our optimization efforts included primer and probe configurations, reaction parameters, and guided DNA selection, culminating in a detection threshold of 10 GPV DNA copies per microlitre. The specificity of the proposed method was rigorously validated against a spectrum of avian pathogens. Clinical application to lung tissues from GPV-infected geese yielded a detection concordance of 100%, surpassing that of qPCR and PCR in both rapidity and operational simplicity. The RPA-PfAgo system has emerged as a revolutionary diagnostic modality for managing this disease, as it is a promising rapid, economical, and onsite GPV detection method amenable to integration into broad-scale disease surveillance frameworks. Future explorations will extend the applicability of this method to diverse avian diseases and assess its field utility across various epidemiological landscapes.
快速准确地检测鹅细小病毒(GPV)对于控制疫情爆发和减轻其对家禽业的经济影响至关重要。本研究介绍了重组酶聚合酶扩增结合 Pyrococcus furiosus argonaute(RPA-PfAgo)系统,这是一种新颖的诊断平台,旨在解决传统 GPV 检测方法的局限性。利用 RPA 的快速 DNA 扩增和 PfAgo 蛋白对核酸的严格切割,RPA-PfAgo 系统在检测 GPV 方面具有高特异性和高灵敏度。我们的优化工作包括引物和探针的配置、反应参数和引导 DNA 的选择,最终检测阈值达到每微升 10 个 GPV DNA 拷贝。该方法的特异性经过严格验证,可与一系列禽病原体区分开来。该方法在感染 GPV 的鹅的肺组织中的临床应用具有 100%的检测一致性,在快速性和操作简便性方面均优于 qPCR 和 PCR。RPA-PfAgo 系统已成为管理这种疾病的一种革命性诊断方式,因为它是一种有前途的快速、经济且可现场进行的 GPV 检测方法,适合纳入广泛的疾病监测框架。未来的研究将扩展该方法在各种禽病中的适用性,并评估其在不同流行病学环境下的现场实用性。